Sunbelt Securities’s NovoCure NVCR Stock Holding History

Sunbelt Securities’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44	Hold	4	–	–	﹤0.01%	2790
2025 Q4	$52	Hold	4	–	–	﹤0.01%	2636
2025 Q3	$52	Hold	4	–	–	﹤0.01%	2592
2025 Q2	$119	Hold	4	–	–	﹤0.01%	1761
2025 Q1	$71	Hold	4	–	–	﹤0.01%	1765
2024 Q4	$120	Hold	4	–	–	﹤0.01%	1766
2024 Q3	$63	Hold	4	–	–	﹤0.01%	1818
2024 Q2	$69	Sell	4 -3	-43%	-$53	﹤0.01%	1736
2024 Q1	$109	Hold	7	–	–	﹤0.01%	1693
2023 Q4	$105	Sell	7 -23	-77%	-$308	﹤0.01%	1660
2023 Q3	$484	Hold	30	–	–	﹤0.01%	1657
2023 Q2	$1.25K	Sell	30 -17	-36%	-$1.06K	﹤0.01%	1495
2023 Q1	$2.74K	Buy	+47	New	+$3.76K	﹤0.01%	1393

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Sunbelt Securities's NVCR Position: Q1 2026 in Review

Sunbelt Securities held its NovoCure (NVCR) position steady in Q1 2026 at 4 shares worth $44. The position accounts for ﹤0.01% of the portfolio, ranked #2790.

Sunbelt Securities first reported a position in NVCR in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.74K in Q1 2023. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

Sunbelt Securities held 4 shares of NovoCure worth $44 as of Q1 2026.
Sunbelt Securities left its NovoCure share count unchanged in Q1 2026.
NovoCure made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2790 holding.
Sunbelt Securities first reported a position in NovoCure in Q1 2023 and has held it in 13 quarters since.
Sunbelt Securities's NovoCure position peaked at $2.74K in Q1 2023.
222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.